About Bara Vaida
Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico, The Washington Post and other outlets.
The race to develop a vaccine against SARS-CoV2, the virus that causes COVID-19, is picking up speed with early promising results from initial studies, and President Trump predicting there will be “hundreds of millions of doses” of vaccine by the end of 2020.
Journalists have reported on these early results, as well as Trump’s comments, which may leave the public with a misunderstanding about the process of vaccine development. Continue reading →
Bara Vaida (@barav) is AHCJ's core topic leader on infectious diseases. An independent journalist, she has written extensively about health policy and infectious diseases. Her work has appeared in the National Journal, Agence France-Presse, Bloomberg News, McClatchy News Service, MSNBC, NPR, Politico, The Washington Post and other outlets.